Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pain Patch

Settling antitrust claims with the state of California on Friday, pharmaceutical company Endo agreed to pay $760,000 and not strike deals with generic drugmakers without state approval as it did to delay a generic version of its Lidoderm pain patch in 2012.

SAN FRANCISCO – Settling antitrust claims with the state of California on Friday, pharmaceutical company Endo agreed to pay $760,000 and not strike deals with generic drugmakers without state approval as it did to delay a generic version of its Lidoderm pain patch in 2012.

Categories / Business, Courts

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...